To study the association of premenstrual serum total cholesterol level (TC) with premenstrual dysphoric disorder (PMDD).
Method:
The premenstrual serum cholesterol levels of 34 patients with PMDD and 20 normal controls were measured, and the rates of hypercholesterolemia in the 2 groups were compared.
Results:
The mean of the premenstrual cholesterol level of the study group was 180.82 + 34.47 mg/dL, while that of the control group was 162.45 + 21.29 mg/dL (t = 2.152, df = 52, p = 0.036). The prevalence of premenstrual hypercholesterolemia (serum total cholesterol > 200 mg/dL) was 23.53% (8/34) in the PMDD group and zero in the normal control group (chi-square=5.524, df = 1, p = 0.019).
Conclusion:
The results showed elevated premenstrual serum cholesterol in PMDD and implied a new direction of research to further explore the etiology of PMDD. It is suggested that the pathophysiology of premenstrual dysphoric disorder may be similar to that of anxiety disorders.
ZureikMCourbonDDucimetièreP. Serum cholesterol concentration and death from suicide in men: Paris prospective study I. British Medical Journal1996; 313: 649–651.
4.
JowGMYangTTChenCL. Leptin and cholesterol levels are low in major depressive disorder, but high in schizophrenia. Journal of Affective Disorders2006; 90: 21–27.
5.
WellsASReadNWLaugharneJDEAhlumaliaNS. Alterations in mood after changing to a low-fat diet. British Journal of Nutrition1998; 79: 23–30.
6.
TeraoTIwataNKanazawaKTakanoTTakahashiNHayashiT. Low serum cholesterol levels and depressive state in human dock visitors. Acta Psychiatrica Scandinavica2000; 101: 231–234.
7.
AtmacaMKulogluMTezcanEUstundagB. Serum leptin and cholesterol levels in patients with bipolar disorder. Neuropsychobiology2002; 46: 176–179.
8.
MuldoonMFBachenEAManuckSB. Acute cholesterol responses to mental stress and change in posture. Archives of Internal Medicine1992; 152: 775–780.
9.
PetersonJKeithRWilcoxA. Hourly changes in serum cholesterol. Circulation1962; 25: 798.
10.
DimsdaleJEHerdJA. Variability of plasma lipids in response to emotional arousal. Psychosomatic Medicine1982; 44: 413–430.
11.
HaywardCTaylorCBRothWTKingRAgrasWS. Plasma lipid levels in patients with panic disorder or agoraphobia. American Journal of Psychiatry1989; 146: 917–919.
12.
BajwaWKAsnisGMIrfanSanderson Avan PraagHM. High cholesterol levels in patients with panic disorder. American Journal of Psychiatry1992; 149: 376–378.
13.
TancerMESteinMBMoulDEUhdeTW. Normal serum cholesterol in panic disorder. Biology and Psychiatry1990; 27: 99–101.
14.
ReifmanAWindleM. High cholesterol levels in patients with panic disorder. American Journal of Psychiatry1993; 150: 527.
American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders (4th Edition), Washington, DC, 1994.
17.
YonkersKA. The association between premenstrual dysphoric disorder and other mood disorders. Journal of Clinical Psychiatry1997; 58(15, suppl): 19–25.
18.
YonkersKA. Anxiety symptoms and anxiety disorders: How are they related to premenstrual disorders?Journal of Clinical Psychiatry1997; 58(3, suppl): 62–69.
19.
VickersKMcNallyRJ. Is premenstrual dysphoria a variant of panic disorder? A review. Clinical Psychology Review2004; 24: 933–956.
20.
HsiaoMCLiuCYChenKCHsiehTT. Characteristics of women using a mental health clinic in a gynecologic outpatient setting. Psychiatry and Clinical Neurosciences2002; 56: 459–463.
21.
HsiaoMCLiuCYChenKCHsiehTT. Characteristics of women seeking treatment for premenstrual syndrome in Taiwan. Acta Psychiatrica Scandinavica2002; 106: 150–155.
22.
ReidRL. Premenstrual syndrome. Current Problems in Obstetrics, Gynecology, and Fertility1985; 8: 43–67.
23.
SheehanDVLecrubierYSheehanKHAmorimPJanavsJWeillerE. The Mini-International Neuropsychiatric Interview (MINI): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry1998; 59(20 suppl): 22–33.
24.
World Health Organization.Mental, Behavioral and Developmental Disorders. Tenth Revision of the International Classification of Diseases (ICD-10). Geneva: World Health Organization, 1996.
25.
AllenJKBlumenthalRSMargolisSYoungDRMillerERIIIKellyK. Nurse case management of hypercholesterolemia in patients with coronary heart disease: Results of a randomized clinical trial. American Heart Journal2002; 144: 678–686.
26.
CerinACollinsALandgrenBMEnerothP. Hormonal and biochemical profiles of premenstrual syndrome. Treatment with essential fatty acids. Acta Obstetrics and Gynecology Scandinavica1993; 72: 337–343.
27.
KaganBLLeskinGHaasBWilkinsJFoyD. Elevated lipid levels in Vietnam veterans with chronic posttraumatic stress disorder. Biology and Psychiatry1999; 45: 374–379.
28.
FeedmanDSByersTBarrettDHStroupNEEakerEMonroe-BlumE. Plasma lipid levels and psychologic characteristics in men. American Journal of Epidemiology1995; 141: 507–517.
29.
KuczmierczykARBarbeeJGBolognaNATownsendMH. Serum cholesterol levels in patients with generalized anxiety disorder (GAD) and with GAD and comorbid major depression. Canadian Journal of Psychiatry1996; 41: 465–468.
30.
HarrisonWMSandbergDGormanJMFyerMNeeJUyJ. Provocation of panic with carbon dioxide inhalation in patients with premenstrual dysphoria. Psychiatry Research1989; 27: 183–192.
SandbergDEndicottJHarrisonWNeeJGormanJ. Sodium lactate infusion in late luteal phase dysphoric disorder. Psychiatry Research1993; 46: 79–88.
33.
KentJMPappLAMartinezJMBrowneSTCoplanJDKleinDF. Specificity of panic response to CO2 inhalation in panic disorder: A comparison with major depression and premenstrual dysphoric disorder. American Journal of Psychiatry2001; 158: 58–67.
34.
GiulioGDReissingED. Premenstrual dysphoric disorder: Prevalence, diagnostic considerations, and controversies. Journal of Psychosomatic Obstetrics and Gynecology2006; 27: 201–210.
35.
LandénMErikssonE. How does premenstrual dysphoric disorder relate to depression and anxiety disorders?Depression & Anxiety2003; 17: 122–129.
36.
HalbreichUPettyFYonkersKKramerGLRushAJBibiKW. Low plasma gamma-aminobutyric acid levels during the late luteal phase of women with premenstrual dysphoric disorder. American Journal of Psychiatry1996; 153: 718–720.
37.
GurguisGNYonkersKAPhanSPBlakeleyJEWilliamsARushAJ. Adrenergic receptors in premenstrual dysphoric disorder, I: Platelet x2 receptors: Gi protein coupling, phase of menstrual cycle, and prediction of luteal phase symptom severity. Biology and Psychiatry1998; 44: 600–609.
38.
SundstromIAnderssonANybergSAshbrookDPurdyRHBackstromT. Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects. Neuroendocrinology1998; 67: 126–138.
